Viewing Study NCT03276832


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2026-01-09 @ 7:42 PM
Study NCT ID: NCT03276832
Status: COMPLETED
Last Update Posted: 2025-10-28
First Post: 2017-09-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Sponsor: Mayo Clinic
Organization: